Literature DB >> 15800484

Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.

Yoshihiro Sakamoto1, Tomoo Kosuge, Kazuaki Shimada, Tsuyoshi Sano, Hidenori Ojima, Junji Yamamoto, Susumu Yamasaki, Tadatoshi Takayama, Masatoshi Makuuchi.   

Abstract

BACKGROUND: The surgical outcome of middle and/or distal bile duct cancer remains unsatisfactory. Although the resectional margin is known to be a predictive factor, the prognostic significance of a positive ductal margin and other radial margin has never been evaluated independently.
METHODS: The clinicopathologic data of 55 patients who had undergone surgical resection for middle and/or distal bile duct cancer between 1987 and 2003 were reviewed retrospectively. The surgical procedures consisted of pancreatoduodenectomy in 42 patients (76%), extrahepatic bile duct resection in 8 patients (15%), major hemihepatectomy (Hx) in 3 patients (5%), and pancreatoduodenectomy plus Hx in 2 patients (4%). In all the patients, intraoperative diagnosis of the ductal margins was performed using frozen sections. Twenty-one clinicopathologic factors, including the status of the ductal margins and of other radial margins, were evaluated using univariate and multivariate analyses.
RESULTS: The overall 5-year survival rate and the median survival time were 24% and 38 months, respectively. There were 4 (7%) postoperative deaths. Fifteen of the remaining 51 patients (29%) were determined to have positive hepatic-side ductal margins during operation, and 14 of them underwent additional resection of the bile duct (1.6[range, 1-3] times, on average). As a result, hepatic-side ductal margin (hm) and duodenal-side ductal margin were found to be positive in 6 and 0 patients on the final pathologic analysis, respectively. Two of the 6 patients (33%) with positive hm have developed ductal recurrence so far, but the status of hm was not found to be a significant predictor. The depth of neoplastic invasion into the bile duct wall, pancreatic invasion, radial margin, and blood transfusion were significant prognostic factors by the univariate analysis. Multivariate analysis revealed that the depth of neoplastic invasion and blood transfusion were the independent prognostic factors.
CONCLUSIONS: In the treatment of middle and distal bile duct cancer, it is of importance to secure a negative radial margin, although it may be less beneficial to obtain a negative hm. Surgeons should make efforts to obtain negative radial margins and to avoid blood transfusion.

Entities:  

Mesh:

Year:  2005        PMID: 15800484     DOI: 10.1016/j.surg.2004.10.008

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  44 in total

1.  Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo; Hiroki Ohge; Taijiro Sueda
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

2.  Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.

Authors:  Ryoko Sasaki; Yuichiro Takeda; Osamu Funato; Hiroyuki Nitta; Hidenobu Kawamura; Noriyuki Uesugi; Tamotsu Sugai; Go Wakabayashi; Nobuhiro Ohkohchi
Journal:  World J Surg       Date:  2007-07-25       Impact factor: 3.352

3.  A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen.

Authors:  Mahmoud A Khalifa; Vlad Maksymov; Corwyn H Rowsell; Sherif Hanna
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 4.  Classifying extrahepatic bile duct metachronous carcinoma by de novo neoplasia site.

Authors:  Hyung Jun Kwon; Sang Geol Kim; Jae Min Chun; Yoon Jin Hwang
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

5.  Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients.

Authors:  Yoshihiro Sakamoto; Kazuaki Shimada; Satoshi Nara; Minoru Esaki; Hidenori Ojima; Tsuyoshi Sano; Junji Yamamoto; Tomoo Kosuge
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

Review 6.  Laparoscopy in the management of hilar cholangiocarcinoma.

Authors:  Akihiro Cho; Hiroshi Yamamoto; Osamu Kainuma; Yorihiko Muto; Hiroo Yanagibashi; Toru Tonooka; Takahito Masuda
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

7.  Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.

Authors:  Megan E McNally; Amy Collins; Sylwia E Wojcik; James Liu; Jon C Henry; Jinmai Jiang; Thomas Schmittgen; Mark Bloomston
Journal:  HPB (Oxford)       Date:  2012-07-04       Impact factor: 3.647

8.  Is it possible to define early distal cholangiocarcinoma?

Authors:  Fumihiko Miura; Keiji Sano; Hodaka Amano; Naoyuki Toyota; Keita Wada; Takuo Tokairin; Fukuo Kondo; Koichi Hayano; Hisahiro Matsubara; Tadahiro Takada
Journal:  Langenbecks Arch Surg       Date:  2015-10-30       Impact factor: 3.445

9.  Carcinoma of the middle bile duct: is bile duct segmental resection appropriate?

Authors:  Hyung-Geun Lee; Sang-Hoon Lee; Dong-Do Yoo; Kwang-Yeol Paik; Jin-Seok Heo; Seong-Ho Choi; Dong-Wook Choi
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

10.  Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.

Authors:  Satoshi Kondo; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Masato Nagino; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Masakazu Yamamoto; Masato Kayahara; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Satoshi Hirano; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.